Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-19
2011-07-19
Moore, Susanna (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S280000
Reexamination Certificate
active
07981902
ABSTRACT:
A compound for treating cancer tumors, particularly ovarian cancer tumors, is described, where a fused cyclic pyrimidine having a cancer treating ability is effective to allow selective delivery to a cancerous tumor.
REFERENCES:
patent: 5939420 (1999-08-01), Gangjee
patent: 0438261 (1991-07-01), None
Aleem Gangjee, Yibin Zeng, John J.L McGuire, and Roy L. Kisliuk, Synthesis of Classic Four-Carbon Bridged 5-Substituted Furo [2,3-d] pyrimidine and 6-Substituted Pyrrolo [2,3-d] pyrimid Analogues as Antifolates, J. Medical Chemistry 2005, pp. 5329-5336.
Buchanan & Ingersoll & Rooney PC
Cochenour Craig G.
Duquesne University of the Holy Ghost
Moore Susanna
LandOfFree
Substituted pyrrolo[2,3-d]pyrimidines for selectively... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrrolo[2,3-d]pyrimidines for selectively..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrrolo[2,3-d]pyrimidines for selectively... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2711228